R-Chop Is Not Effective Regimen in CD5(+)DLBCL Diagnosed by Flow-Cytometry/Immunohistochemistry, Karyotype and BCL2/BCL6 Status and Expression

Hematological Oncology - United Kingdom
doi 10.1002/hon.2439_78
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Elevated Expression of Lag3 Is Associated With Poor Outcome in Patients With DLBCL Treated With R-Chop

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

MYC Expression in Concert With BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

PLoS ONE
Multidisciplinary
2014English

Negative Impact of Zoledronic Acid in R-Chop Treated DLBCL With Bone Metastasis

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Prescribed Regimen Is Effective

BMJ
2010English

Predictive Value of Interim PET/CT in DLBCL Treated With R-Chop: Meta-Analysis

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

Clinical Significance and Outcomes in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) Harboring Extra Copies [Ec] and/or Translocations [Tl] of Myc, Bcl2, and Bcl6

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Granisetron Plus Aprepitant Versus Granisetron in Preventing Nausea and Vomiting During CHOP or R-Chop Regimen in Malignant Lymphoma: A Retrospective Study

Journal of Pharmaceutical Health Care and Sciences
2019English

Addition of Lenalidomide to R-Chop (R2chop) Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma (Dlbcl): First Report of Ecog-Acrin1412 a Randomized Phase 2 Us Intergroup Study of R2chop vs R-Chop

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Bet Inhibitor Rg6146, Venetoclax, and Rituximab Is a Highly Active Regimen in Relapsed/Refractory (R/R) Dlbcl: Initial Report of Phase 1b Safety, Biomarker, and Response Data

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy